Press releases
- Photocure ASA - Notice of the Annual General Meeting 23 May 2024
- Photocure ASA: Annual Report 2023
- European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
- Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
- Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
- Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
- Photocure ASA: Results for the fourth quarter of 2023
More ▼
Key statistics
On Tuesday, Photocure ASA (PHS:DUS) closed at 4.78, 5.99% above its 52-week low of 4.51, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.78 |
---|---|
High | 4.78 |
Low | 4.78 |
Bid | 4.59 |
Offer | 4.80 |
Previous close | 4.69 |
Average volume | 0.00 |
---|---|
Shares outstanding | 27.12m |
Free float | 26.68m |
P/E (TTM) | 7,701.95 |
Market cap | 1.50bn NOK |
EPS (TTM) | 0.0072 NOK |
Data delayed at least 15 minutes, as of Apr 30 2024 07:12 BST.
More ▼